Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...

Researchers suggest results could reignite interest in DLK inhibition as a treatment strategy for neurodegenerative diseases.

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...

Sponsored content brought to you by NGS continually delivers breakthroughs in genomics, and to do so, it relies on the crucial step of sample preparation. Complex and expensive workflows are ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies.

Study in older adults found that individuals who received the shingles vaccine were 20% less likely to develop dementia than those who were unvaccinated.

IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

In episode one of this podcast, you’ll hear a group of experts discussing base editing and how the technology is helping ...

Research identifies MDGA2- BDNF/TrkB-dependent mechanism that may point to therapeutic approaches for autism spectrum ...

AIR-001 is designed to restore functional alpha-1 antitrypsin (M-AAT) protein production by precisely repairing the SERPINA1 mutation (PiZ) to address the underlying cause of both lung and liver ...